Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer

NCT02588105 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumours

Interventions

DRUG: AZD0156
DRUG: Olaparib
DRUG: irinotecan
DRUG: Fluorouracil
DRUG: Folinic Acid

Sponsor

AstraZeneca

Collaborators

[object Object]